16th Annual Report 2011-12 - Fortis Healthcare

44 16th Annual Report 2011-12 Operations Review
North India, primarily in Delhi
& NCR. The vision is to bring a
Renkare dialysis centre within
easy reach of patients, across the
Indian sub-continent, with the
goal of providing high quality
affordable dialysis to all those who
need it.
cases addressed are from Jammu &
Kashmir, Haryana, Uttar Pradesh,
Uttarakhand, Bihar, and Assam.
Fortis C-DOC provides
services ranging from specialised
investigations, therapy for
treatment and management
of diabetes and other comorbid
problems, consultation
by a dedicated consortium of
acclaimed experts through
advanced centres for the diabetic
foot and vascular investigation
lab, speciality clinics like Retina
lab for diabetic eye, diabetic foot
care, hyperbaric oxygen therapy
(HBOT) for wound management;
amputation prevention centre;
vascular disorders and surgery;
insulin pump therapy offering
continuous glucose monitoring
service, lifestyle modification
management, etc.
Renkare
Renkare, a Fortis Healthcare
enterprise, is a chain of state-ofthe-art
dialysis centres providing
services like Haemodialysis,
Consultations, Diagnostics and
Pharmacy.
Manned by a team of talented
and experienced renal specialists
and equipped with state-of-theart
equipment and technology,
Renkare offers Excellence in
Dialysis through reliable, safe and
effective services in a hygienic
and home-like environment. The
centres focus on educational
programmes to help patients
live a reasonably healthy and
productive life, even while on
haemodialysis. Renkare centres
follow standardised, international
dialysis protocols, including the
unique Water Testing Protocol,
combined with a meticulously
clean environment and have other
comforts like reclining chairs,
WiFi connectivity and personal
LCD screens for a relaxed dialysis
experience. Renkare is currently
operational in five locations in
Fortis General
To address the need of
underserved patient systems,
Fortis launched a secondary care
format brand ‘Fortis General’.
Fortis General will provide
quality, reliable, accessible, and
affordable healthcare to the
growing middle class. It will
primarily (may not be exclusively)
focus on cities outside metros
and tier-I cities, substantially
increasing the geographic and
demographic reach of the Fortis
healthcare delivery network. It
will open up a new segment as
more than 46% of the patients in
tier II and tier III cities travel over
100kms from small towns and
rural areas to seek medical care.
Low land cost and availability will
also facilitate expansion.
SRL Ltd
SRL Ltd is focused on
consolidating its leadership
position in the country and
expanding its presence to new
market segments. The company
increased its footprint in India
with an established strength of
over 210 labs, over 1100 sample
collection centres, 21 wellness
centres and 23 Company Owned
and Operated centres. This rapid
expansion was simultaneously
accompanied with a strong focus
on quality diagnostic services
which helped to strengthen SRL’s
equity among doctors and patients.